TG
PFE icon

TLP Group’s Pfizer PFE Stock Holding History

TLP Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$35K Sell
25,296
-18,445
-42% -$671K 0.53% 14
2019
Q2 		$161K Buy
43,741
+25,296
+137% +$1M 2.99% 8
2019
Q1 		$25K Hold
18,445
– – 0.35% 11
2018
Q4 		$49K Sell
18,445
-76,415
-81% -$3.17M 0.18% 40
2018
Q3 		$531K Buy
+94,860
New +$3.65M 0.84% 18

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TLP Group's PFE Position: Q3 2019 in Review

TLP Group reduced its Pfizer (PFE) stake by 95% in Q3 2019, selling an estimated $8.24M and leaving 12,016 shares worth $410K. The position accounts for 6.2% of the portfolio, ranked #5.

TLP Group first reported a position in PFE in Q4 2015 and has held it in 10 quarters since. The position peaked at $3.79M in Q4 2017. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • TLP Group held 12,016 shares of Pfizer worth $410K as of Q3 2019.
  • TLP Group sold 226,715 Pfizer shares in Q3 2019, an estimated $8.24M.
  • Pfizer made up 6.2% of TLP Group's portfolio in Q3 2019, its #5 holding.
  • TLP Group first reported a position in Pfizer in Q4 2015 and has held it in 10 quarters since.
  • TLP Group's Pfizer position peaked at $3.79M in Q4 2017.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on TLP Group's 13F filing for Q3 2019, filed 11 Oct 2019.